Screening for chronic kidney disease
Chronic Kidney Disease Screening in Patients Followed at a Tertiary Care Center
Institute for Clinical and Experimental Medicine · NCT07153432
We will see how common chronic kidney disease is among adults followed at a tertiary care center and how many cases were previously undiagnosed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institute for Clinical and Experimental Medicine (other gov) |
| Locations | 1 site (Prague) |
| Trial ID | NCT07153432 on ClinicalTrials.gov |
What this trial studies
This observational project enrolls adults followed at the Institute for Clinical and Experimental Medicine who are over 50 or adults 18+ with specified cardiovascular or metabolic risk conditions. Participants provide consent for review of medical records and available laboratory data, and kidney function indicators such as eGFR and urine testing will be used where present. The main outcome is the proportion of patients meeting criteria for chronic kidney disease and the share who were not previously diagnosed. Findings will describe prevalence and patterns across risk groups to inform local screening and care priorities.
Who should consider this trial
Good fit: Adults followed at the Institute for Clinical and Experimental Medicine who are older than 50, or adults 18+ with diabetes, hypertension, ischemic heart disease, stroke, peripheral artery disease, atrial fibrillation, or heart failure, and who agree to participate are ideal candidates.
Not a fit: Kidney transplant recipients, people not followed at the Institute, or those already in active nephrology care are unlikely to benefit from this screening-focused project.
Why it matters
Potential benefit: If successful, the work could identify people with previously unrecognized CKD so they can get earlier management to slow progression.
How similar studies have performed: Similar epidemiologic screening studies have commonly found substantial amounts of undiagnosed CKD, so the approach is established rather than novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age \> 50 or age \>18 + one of these conditions (history of diabetes, arterial hypertension, ischemic heart disease, stroke, perpheral artery disease, atrial fibrillation, heart failure) * agree to participate * followed at the Institute for Clinical and Experimental Medicine Exclusion Criteria: * unwilling to participate * kidney transplant recipient/previous kidney transplantation
Where this trial is running
Prague
- Institute for Clinical and Experimental Medicine — Prague, Czechia (RECRUITING)
Study contacts
- Study coordinator: Ivan Zahradka, MD
- Email: zahi@ikem.cz
- Phone: +420261364110
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Kidney Diseases, chronic kidney disease, screening, epidemiology